CCR1 and plasma cell myeloma: In line with this, high levels of CCL3 was found in the bone marrow of patients with multiple myeloma (30), and anti-CCR1 and anti-CCR5 blocking antibodies inhibit the adherence of myeloma cells to bone marrow stroma cells in vitro (31).